Skip to main content
Clinical Trials/JPRN-UMIN000024257
JPRN-UMIN000024257
Completed
未知

Association of changes in dyspnea, lung function, and physical activity by Indacaterol/Glycopyrronium combination in patients with COPD - Changes in lung function and physical activity by LAMA/LABA therapy in COPD

Yamaguchi University0 sites45 target enrollmentOctober 10, 2016
ConditionsCOPD

Overview

Phase
未知
Intervention
Not specified
Conditions
COPD
Sponsor
Yamaguchi University
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2016
End Date
October 5, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Moderate\-to\-severe COPD exacerbation (requiring antibiotics, systemic steroids or hospitalization) within the 4 weeks before the screening 2\)Requiring LABA and LAMA combination therapy 3\)Requiring long\-term oxygen therapy 4\)Requiring short\-acting beta2\-agonista (SABA) relief use of more than 8 puffs/day 5\)Concomitant pulmonary disease including asthma (FeNO\<50ppb at baseline) 6\)Any physical disorder that would prevent the patient from being able to complete the assessments 7\)Long QT syndrome at screening, or a clinically significant electrocardiogram abnormality 8\)History of closed angle glaucoma, and/or ischuria due to prostatic disease 9\) There is a history of hypersensitivity to components of the Urutiburo

Outcomes

Primary Outcomes

Not specified

Similar Trials